Cingulate Inc. (CING) stock
CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
$4.64+0.08 (+1.75%)
Close on Nov 11, 2026Market cap $67.47MP/E –Yield –
Cingulate enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cingulate's enterprise value was $36.07M on Nov 11, 2026, against $16.18M a year earlier. Over the last 5 years it ranged from $1.02M to $269.97M, with a median of $38.42M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $36.07M | +82.0% |
| 2025 | Dec 31, 2025 | $19.82M | +299.0% |
| 2024 | Dec 31, 2024 | $4.97M | -94.0% |
| 2023 | Dec 29, 2023 | $83.48M | -38.4% |
| 2022 | Dec 30, 2022 | $135.62M | – |
See a number that looks wrong?